{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:13:52Z","timestamp":1783660432235,"version":"3.55.0"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Obesity is a chronic multifactorial metabolic disorder characterized by adipose tissue dysfunction, insulin resistance, low-grade inflammation, and altered energy homeostasis. Evidence indicates that the gut microbiota contributes to obesity-related metabolic dysfunction through microbial metabolite production, intestinal barrier regulation, immune activation, bile acid signaling, and gut\u2013brain communication. This narrative review, supported by a structured literature search, synthesizes current evidence on the gut microbiota\u2013obesity axis and the potential role of tirzepatide in modulating microbiota-related metabolic pathways. Microbiota-derived metabolites, including short-chain fatty acids, bile acids, tryptophan derivatives, trimethylamine N-oxide, and fatty acid-derived compounds, may exert beneficial, detrimental, or context-dependent effects depending on microbial composition, diet, host metabolic status, and tissue-specific signaling pathways. Lifestyle, dietary patterns, host genetics, and medication exposure can further modulate gut microbiota composition and function, influencing metabolic outcomes. Tirzepatide, a dual glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist, improves glycemic control and promotes weight loss. Evidence suggests that tirzepatide may also be associated with changes in gut microbiota composition, microbial metabolites, intestinal barrier integrity, and inflammatory signaling. However, whether these microbial changes represent direct pharmacological effects or secondary consequences of weight loss, reduced caloric intake, delayed gastric emptying, improved glucose control, or dietary modification remains unclear. This review summarizes current evidence on the gut microbiota\u2013obesity axis and the potential relevance of tirzepatide-associated microbiota modulation.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1901528","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:25:37Z","timestamp":1783657537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Tirzepatide and the gut microbiota\u2013obesity axis: metabolic mechanisms and therapeutic perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Santiago","family":"Cadena-Ullauri","sequence":"first","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s S.","family":"Cadena Paredes","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len\u00edn","family":"Guam\u00e1n-Herrera","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhon","family":"Imbaquingo-Espinales","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana A.","family":"Ruiz-Pozo","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Tamayo-Trujillo","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Guevara-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elius","family":"Paz-Cruz","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karina","family":"Zambrano","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"999001","DOI":"10.3389\/fmicb.2022.999001","article-title":"Human gut microbiota in health and disease: unveiling the relationship","volume":"13","author":"Afzaal","year":"2022","journal-title":"Front. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/imr.12180","article-title":"Microbiota activation and regulation of innate and adaptive immunity","volume":"260","author":"Alexander","year":"2014","journal-title":"Immunol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"177979","DOI":"10.1016\/j.ejphar.2025.177979","article-title":"A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease","volume":"1003","author":"Alshehri","year":"2025","journal-title":"Eur. J. Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"171216","DOI":"10.1016\/j.peptides.2024.171216","article-title":"Incretin hormones, obesity and gut microbiota","volume":"178","author":"Angelini","year":"2024","journal-title":"Peptides"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e24420","DOI":"10.1002\/jcla.24420","article-title":"Obesity and gut\u2013microbiota\u2013brain axis: a narrative review","volume":"36","author":"Asadi","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.3390\/nu14193985","article-title":"Beneficial effects of anti-inflammatory diet in modulating gut microbiota and controlling obesity","volume":"14","author":"Bagheri","year":"2022","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"171380","DOI":"10.1016\/j.peptides.2025.171380","article-title":"Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities","volume":"187","author":"Bailey","year":"2025","journal-title":"Peptides"},{"key":"B9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/00185787221125724","article-title":"Tirzepatide","volume":"58","author":"Baker","year":"2024","journal-title":"Hosp. Pharm."},{"key":"B10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-12-804024-9.00029-X","article-title":"\u201cRelationship between gut microbiota, energy metabolism, and obesity,\u201d","volume-title":"The Microbiota in Gastrointestinal Pathophysiology: implications for Human Health, Prebiotics, Probiotics, and Dysbiosis","author":"Bakker","year":"2017"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41591-026-04284-y","article-title":"Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals","volume":"32","author":"Baldanzi","year":"2026","journal-title":"Nat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.3390\/ijerph17207618","article-title":"The gut microbiota and inflammation: an overview","volume":"17","author":"Bander","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature07450","article-title":"Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis","volume":"456","author":"Bouskra","year":"2008","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41538-024-00253-2","article-title":"(2024). Gamma-aminobutyric acid as a potential postbiotic mediator in the gut\u2013brain axis","volume":"8","author":"Braga","year":"2024","journal-title":"NPJ Sci. Food"},{"key":"B15","doi-asserted-by":"publisher","first-page":"971048","DOI":"10.3389\/fimmu.2022.971048","article-title":"Sex hormones, intestinal inflammation, and the gut microbiome: major influencers of the sexual dimorphisms in obesity","volume":"13","author":"Brettle","year":"2022","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e02244","DOI":"10.1128\/AAC.02244-18","article-title":"Ceftriaxone and cefotaxime have similar effects on the intestinal microbiota in human volunteers treated by standard-dose regimens","volume":"63","author":"Burdet","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1589726","DOI":"10.3389\/fcell.2025.1589726","article-title":"Microbiota dysbiosis impact on the metabolism of T3 and T4 hormones and its association with thyroid cancer","volume":"13","author":"Cadena-Ullauri","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1393292","DOI":"10.3389\/fnut.2024.1393292","article-title":"The effect of intermittent fasting on microbiota as a therapeutic approach in obesity","volume":"11","author":"Cadena-Ullauri","year":"2024","journal-title":"Front. Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.3390\/ijms22126242","article-title":"Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases","volume":"22","author":"Candelli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.molmet.2016.05.011","article-title":"How gut microbes talk to organs: the role of endocrine and nervous routes","volume":"5","author":"Cani","year":"2016","journal-title":"Mol. Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9734845","DOI":"10.1155\/2018\/9734845","article-title":"Phytochemicals that influence gut microbiota as prophylactics and for the treatment of obesity and inflammatory diseases","volume":"2018","author":"Carrera-Quintanar","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s44324-024-00030-5","article-title":"Incretin-based therapies for the treatment of obesity-related diseases","author":"Caruso","year":"2024","journal-title":"NPJ Metab. Health Dis. 2"},{"key":"B24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7570\/jomes.2017.26.3.161","article-title":"Intestinal microbiota contributes to energy balance, metabolic inflammation, and insulin resistance in obesity","volume":"26","author":"Cavallari","year":"2017","journal-title":"J. Obes. Metab. Syndr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41591-025-04009-7","article-title":"Multi-omic definition of metabolic obesity through adipose tissue\u2013microbiome interactions","volume":"32","author":"Chakaroun","year":"2026","journal-title":"Nat. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.scib.2025.04.010","article-title":"Multi-omic analyses of the development of obesity-related depression linked to the gut microbe Anaerotruncus colihominis and its metabolite glutamate","volume":"70","author":"Chang","year":"2025","journal-title":"Sci. Bull."},{"key":"B27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jot.2025.09.002","article-title":"Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites","volume":"55","author":"Chen","year":"2025","journal-title":"J. Orthop. Translat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1402583","DOI":"10.3389\/fendo.2024.1402583","article-title":"Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence","volume":"15","author":"Corrao","year":"2024","journal-title":"Front. Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-64833-4","article-title":"Genetic polymorphisms, mediterranean diet and microbiota-associated urolithin metabotypes can predict obesity in childhood-adolescence","volume":"10","author":"Cort\u00e9s-Mart\u00edn","year":"2020","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"O'riordan KJ, Cowan CSM, Sandhu K V., Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/advances\/nmy078","article-title":"Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications","volume":"10","author":"Cuevas-sierra","year":"2019","journal-title":"Adv. Nutr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"De Vos","year":"2022","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.aspetd.2025.100010","article-title":"Pharmacological modulation of the gut microbiota and endotoxemia: a next-generation approach to treating metabolic syndrome","volume":"1","author":"Dimeji","year":"2025","journal-title":"ASPET Discov."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2400385121","DOI":"10.1073\/pnas.2400385121","article-title":"The microbiota-dependent tryptophan metabolite alleviates high-fat diet\u2013induced insulin resistance through the hepatic AhR\/TSC2\/mTORC1 axis","volume":"121","author":"Du","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"36967","DOI":"10.1007\/s11356-021-14593-z","article-title":"Microbiota's role in health and diseases","volume":"28","author":"El-Sayed","year":"2021","journal-title":"Environ. Sci. Pollut. Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"12321","DOI":"10.3390\/ijms252212321","article-title":"The role of gut microbiota in the onset and progression of obesity and associated comorbidities","volume":"25","author":"Enache","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1210\/jc.2002-021437","article-title":"Association of low interleukin-10 levels with the metabolic syndrome in obese women","volume":"88","author":"Esposito","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.nutos.2025.01.011","article-title":"The role of obesity in altering the effects of short chain fatty acids (SCFA) on metabolic hormone regulation: a systematic review and meta-analysis","volume":"60","author":"Faradilah","year":"2025","journal-title":"Clin. Nutr. Open Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S0029665114001463","article-title":"Links between diet, gut microbiota composition and gut metabolism","volume":"74","author":"Flint","year":"2014","journal-title":"Proc. Nutr. Soc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"112678","DOI":"10.1016\/j.biopha.2022.112678","article-title":"The links between gut microbiota and obesity and obesity related diseases","volume":"147","author":"Geng","year":"2022","journal-title":"Biomed. Pharmacother"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/nu17081303","article-title":"Effects of GLP-1 analogues and agonists on the gut microbiota: a systematic review","author":"Gofron","year":"2025","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","article-title":"Human genetics shape the gut microbiome","volume":"159","author":"Goodrich","year":"2014","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14656566.2024.2436595","article-title":"Tirzepatide for overweight and obesity management","volume":"26","author":"Hamza","year":"2025","journal-title":"Expert. Opin. Pharmacother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1126\/science.1188454","volume":"328","author":"Hapfelmeier","year":"2010"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e00819","DOI":"10.1128\/mSystems.00819-20","article-title":"Associations of genetic variants contributing to gut microbiota composition in immunoglobin a nephropathy","volume":"6","author":"He","year":"2021","journal-title":"mSystems"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.2337\/db08-1261","article-title":"Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle","volume":"58","author":"Hong","year":"2009","journal-title":"Diabetes"},{"key":"B49","first-page":"906","article-title":"The impact of tirzepatide on weight management and glycemic control in obese patients","volume":"15","author":"Hossain","year":"2025","journal-title":"Eur. J. Cardiovasc. Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.phrs.2017.01.034","article-title":"Antibiotics, gut microbiota, environment in early life and type 1 diabetes","volume":"119","author":"Hu","year":"2017","journal-title":"Pharmacol. Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3390\/foods13152437","article-title":"Contributions of gamma-aminobutyric acid (GABA) produced by lactic acid bacteria on food quality and human health: current applications and future prospects","volume":"13","author":"Icer","year":"2024","journal-title":"Foods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"200364","DOI":"10.1016\/j.hnm.2026.200364","article-title":"The interplay between gut microbiota metabolites and host body: implications in health and disease","volume":"44","author":"Islam","year":"2026","journal-title":"Hum. Nutr. Metab"},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/19490976.2016.1267890","article-title":"Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers","volume":"8","author":"Kabbani","year":"2016","journal-title":"Gut Microbes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-017-1027-1","article-title":"Association between body mass index and Firmicutes\/Bacteroidetes ratio in an adult Ukrainian population","volume":"17","author":"Koliada","year":"2017","journal-title":"BMC Microbiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/ajpgi.00293.2012","article-title":"ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways","volume":"304","author":"Korecka","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/17512433.2025.2559907","article-title":"Dual incretin agonism and the gut microbiome: does the heart of metabolic regulation beat in the gut?","volume":"18","author":"Koufakis","year":"2025","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e3575","DOI":"10.1210\/clinem\/dgaa382","article-title":"Effect of gut microbiota and PNPLA3 rs738409 variant on nonalcoholic fatty liver disease (NAFLD) in obese youth","volume":"105","author":"Kravetz","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B59","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/14656566.2023.2192865","article-title":"GLP-1\/GIP analogs: potential impact in the landscape of obesity pharmacotherapy","volume":"24","author":"Lafferty","year":"2023","journal-title":"Expert. Opin. Pharmacother."},{"key":"B60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/medsci13040269","article-title":"Incretin-based therapies through the decades: molecular innovations and clinical impact","volume":"13","author":"Lee","year":"2025","journal-title":"Med. Sci."},{"key":"B61","doi-asserted-by":"crossref","unstructured":"Ley\n              R. E.\n            \n            \n              B\u00e4 Ckhed\n              F.\n            \n            \n              Turnbaugh\n              P.\n            \n            \n              Lozupone\n              C. A.\n            \n            \n              Knight\n              R. D.\n            \n            \n              Gordon\n              J. I.\n            \n          \n          10.1073\/pnas.0504978102\n          16033867\n          Obesity Alters Gut Microbial Ecology\n          \n          2005","DOI":"10.1073\/pnas.0504978102"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1136\/gutjnl-2021-325851","article-title":"Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis","volume":"71","author":"Li","year":"2022","journal-title":"Gut"},{"key":"B63","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","article-title":"(2014). An integrated catalog of reference genes in the human gut microbiome","volume":"32","author":"Li","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/microorganisms13030602","article-title":"The potential impact of antibiotic exposure on the microbiome and human health","volume":"13","author":"Li","year":"2025","journal-title":"Microorganisms"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1002\/mco2.171","article-title":"Gut and obesity\/metabolic disease: focus on microbiota metabolites","volume":"3","author":"Lin","year":"2022","journal-title":"MedComm"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.14336\/AD.2022.0104","article-title":"Functions of gut microbiota metabolites, current status and future perspectives","volume":"13","author":"Liu","year":"2022","journal-title":"Aging Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s42255-021-00502-8","article-title":"(2021). Microbial metabolite delta-valerobetaine is a diet-dependent obesogen","volume":"3","author":"Liu","year":"2021","journal-title":"Nat. Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"441","DOI":"10.18553\/jmcp.2025.31.5.441","article-title":"Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: a short-term cost-effectiveness analysis in the United States","volume":"31","author":"Liu","year":"2025","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00592-023-02088-x","article-title":"Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes","volume":"60","author":"Longo","year":"2023","journal-title":"Acta Diabetol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"360","DOI":"10.6133\/apjcn.2014.23.3.16","article-title":"The influence of Mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state","volume":"23","author":"Lopez-Legarrea","year":"2014","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1715024","DOI":"10.3389\/fmolb.2025.1715024","article-title":"Tirzepatide modulates gut microbiota homeostasis to protect against diabetic kidney disease","volume":"12","author":"Ma","year":"2025","journal-title":"Front. Mol. Biosci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"15582","DOI":"10.1038\/s41598-019-52103-x","article-title":"Metabolic and gut microbiome changes following GLP-1 or dual GLP-1\/GLP-2 receptor agonist treatment in diet-induced obese mice","volume":"9","author":"Madsen","year":"2019","journal-title":"Sci. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3748\/wjg.v28.i12.1204","article-title":"Antibiotics, gut microbiota, and irritable bowel syndrome: what are the relations","volume":"28","author":"Mamieva","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biomedicines8060154","article-title":"Free fatty acid receptors 2 and 3 as microbial metabolite sensors to shape host health: pharmacophysiological view","volume":"8","author":"Mishra","year":"2020","journal-title":"Biomedicines"},{"key":"B75","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/biomedicines13020387","article-title":"Fecal short-chain fatty acids are associated with obesity in gestational diabetes","volume":"13","author":"Molan","year":"2025","journal-title":"Biomedicines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3390\/nu12061654","article-title":"The impact of diet on microbiota evolution and human health. Is diet an adequate tool for microbiota modulation?","volume":"12","author":"Moles","year":"2020","journal-title":"Nutrients"},{"key":"B77","doi-asserted-by":"publisher","first-page":"183","DOI":"10.26502\/acbr.50170450","article-title":"Impact of antidepressants on weight gain: underlying mechanisms and mitigation strategies","volume":"9","author":"Mouawad","year":"2025","journal-title":"Arch. Clin. Biomed. Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/ajcn\/nqab150","article-title":"Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: pREDIMED-Plus Study","volume":"114","author":"Muralidharan","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"B79","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0140-6736(25)02105-1","article-title":"Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits","volume":"407","author":"Nauck","year":"2026","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"152822","DOI":"10.1016\/j.bbrc.2025.152822","article-title":"GLP-1 receptor agonists and inflammatory pathway modulation: dual targeting of metabolic and immune dysfunction in insulin resistance","volume":"789","author":"Ngabea","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3390\/cells11182903","article-title":"Elucidation of prebiotics, probiotics, postbiotics, and target from gut microbiota to alleviate obesity via network pharmacology study","volume":"11","author":"Oh","year":"2022","journal-title":"Cells"},{"key":"B82","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4161\/gmic.29558","article-title":"Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial","volume":"5","author":"Pallav","year":"2014","journal-title":"Gut Microbes"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e0066524","DOI":"10.1128\/msystems.00665-24","article-title":"The role of gut microbiome and its metabolites in pancreatitis","volume":"9","author":"Pan","year":"2024","journal-title":"mSystems"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1002\/mbo3.1260","article-title":"Impact of antibiotics on the human microbiome and consequences for host health","volume":"11","author":"Patangia","year":"2022","journal-title":"Microbiologyopen"},{"key":"B85","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s42255-022-00559-z","article-title":"Metabolic messengers: bile acids","volume":"4","author":"Perino","year":"2022","journal-title":"Nat. Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"9254","DOI":"10.3390\/ijms21239254","article-title":"Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells","volume":"21","author":"Pietrzak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/ijms23031105","article-title":"Gut microbiota and short chain fatty acids: implications in glucose homeostasis","volume":"2","author":"Portincasa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B89","unstructured":"Powis\n              J.\n            \n            \n              Thompson\n              R.\n            \n            \n              Jackson-Leach\n              R.\n            \n          \n          Source Information Compiled by Tim Lobstein\n          \n          2025"},{"key":"B90","doi-asserted-by":"publisher","first-page":"13656","DOI":"10.3390\/ijms252413656","article-title":"Pharmacological mechanisms of bile acids targeting the farnesoid X receptor","volume":"25","author":"Qi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"242","DOI":"10.26502\/acmcr.96550740","article-title":"A critical analysis of the clinical use of incretin-based therapies: efficacy and adverse events","volume":"9","author":"Radparvar","year":"2025","journal-title":"Arch. Clin. Med. Case Rep"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1093\/cid\/civ137","article-title":"Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods","volume":"60","author":"Rashid","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/ismej.2014.14","article-title":"Phylogenetic distribution of three pathways for propionate production within the human gut microbiota","volume":"8","author":"Reichardt","year":"2014","journal-title":"ISME J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"B95","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/diseases12090204","article-title":"The effect of tirzepatide on body composition in people with overweight and obesity: a systematic review of randomized, controlled studies","volume":"12","author":"Rochira","year":"2024","journal-title":"Diseases"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13020613","article-title":"Association of gut hormones and microbiota with vascular dysfunction in obesity","volume":"13","author":"Rovella","year":"2021","journal-title":"Nutrients"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2434475","DOI":"10.1080\/09540105.2024.2434475","article-title":"Effect of diet on the microbiota and immune system in patients with systemic lupus erythematosus","volume":"35","author":"Ruiz-Pozo","year":"2024","journal-title":"Food Agric. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s13300-026-01851-x","article-title":"Ambika P\u00b7, Ashraf P, Sasidharan Pillai S, Pillai SS, Ashraf AP (2026). Gut microbiota and metabolic health: from dysbiosis to therapeutics","volume":"17","author":"Sasidharan","year":"2026","journal-title":"Diabetes Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"571731","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front. Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"785833","DOI":"10.3389\/fcimb.2021.785833","article-title":"Short-chain fatty acid and FFAR2 activation \u2013 a new option for treating infections?","volume":"11","author":"Schlatterer","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/17474124.2021.1963232","article-title":"Gut microbiota: a target for intervention in obesity","volume":"15","author":"Sehgal","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/fermentation8080376","article-title":"The role of gut microbiota modulation strategies in obesity: the applications and mechanisms","volume":"8","author":"Shan","year":"2022","journal-title":"Fermentation"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00394-021-02755-1","article-title":"(2022). FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence","volume":"61","author":"Sim\u00f5es","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"B104","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","article-title":"GABA modulating bacteria of the human gut microbiota","volume":"4","author":"Strandwitz","year":"2018","journal-title":"Nat. Microbiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3390\/nu13062045","article-title":"The effects of lifestyle and diet on gut microbiota composition, inflammation and muscle performance in our aging society","volume":"13","author":"Strasser","year":"2021","journal-title":"Nutrients"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3390\/cells11152296","article-title":"Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis","volume":"11","author":"Su","year":"2022","journal-title":"Cells"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e84114","DOI":"10.7759\/cureus.84114","article-title":"The lasting imprint of antibiotics on gut microbiota: exploring long-term consequences and therapeutic interventions","volume":"17","author":"Suvvari","year":"2025","journal-title":"Cureus"},{"key":"B108","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2022.12.013","article-title":"Fatty acid overproduction by gut commensal microbiota exacerbates obesity","volume":"35","author":"Takeuchi","year":"2023","journal-title":"Cell Metab."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1398059","DOI":"10.3389\/fnut.2024.1398059","article-title":"Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity","volume":"11","author":"Tamayo-Trujillo","year":"2024","journal-title":"Front. Nutr"},{"key":"B110","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MS9.0000000000004055","article-title":"A narrative review on tirzepatide's therapeutic potential in glycemic control and cardioprotection","volume":"88","author":"Thiriveedi","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"B111","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2468-1253(17)30147-4","article-title":"The microbiota\u2013gut\u2013brain axis in obesity","volume":"2","author":"Torres-Fuentes","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/life15060843","article-title":"Bidirectional interactions between the gut microbiota and incretin-based therapies","volume":"15","author":"Trapanese","year":"2025","journal-title":"Life"},{"key":"B113","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1588129","DOI":"10.3389\/fimmu.2025.1588129","article-title":"The balance between proinflammatory, \u201cbad,\u201d and immunomodulatory, \u201cgood,\u201d lipopolysaccharide for understanding gut-derived systemic inflammation","volume":"16","author":"Tume","year":"2025","journal-title":"Front Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut lachnospiraceae","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e220271","DOI":"10.1530\/JOE-22-0271","article-title":"Immunology of chronic low-grade inflammation: relationship with metabolic function","volume":"257","author":"van de Vyver","year":"2023","journal-title":"J. Endocrinol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3390\/ijms22062993","article-title":"The role of the gut microbiota in the gut \u2013 brain axis in obesity : mechanisms and future implications","volume":"22","author":"Van Son","year":"2021","journal-title":"Int. J. Mol. Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/nu14102103","article-title":"From gut microbiota through low-grade inflammation to obesity: key players and potential targets","volume":"14","author":"Vetrani","year":"2022","journal-title":"Nutrients"},{"key":"B120","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vich Vila","year":"2020","journal-title":"Nat. Commun."},{"key":"B121","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"B122","doi-asserted-by":"publisher","first-page":"177827","DOI":"10.1016\/j.ejphar.2025.177827","article-title":"The role of gut microbiota in Tirzepatide-mediated alleviation of high-fat diet-induced obesity","volume":"1002","author":"Wang","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s40279-022-01696-x","article-title":"The connection between physical exercise and gut microbiota: implications for competitive sports athletes","volume":"52","author":"Wegierska","year":"2022","journal-title":"Sports Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/nu14010169","article-title":"Nutrition concepts for the treatment of obesity in adults","volume":"14","author":"Wiechert","year":"2022","journal-title":"Nutrients"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.cmet.2021.07.007","article-title":"Intestinal hypoxia-inducible factor 2\u03b1 regulates lactate levels to shape the gut microbiome and alter thermogenesis","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/gutjnl-2018-317155","article-title":"Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice","volume":"68","author":"Wu","year":"2019","journal-title":"Gut"},{"key":"B127","doi-asserted-by":"publisher","first-page":"106690","DOI":"10.1016\/j.phrs.2023.106690","article-title":"Gpr35 shapes gut microbial ecology to modulate hepatic steatosis","volume":"189","author":"Wu","year":"2023","journal-title":"Pharmacol Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1747341","DOI":"10.3389\/fphys.2026.1747341","article-title":"The role of bile acid-activated receptor TGR5 in inflammation and liver diseases","volume":"17","author":"Xiang","year":"2026","journal-title":"Front. Physiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3390\/foods11182863","article-title":"Health benefits and side effects of short-chain fatty acids","volume":"11","author":"Xiong","year":"2022","journal-title":"Foods"},{"key":"B130","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00284-023-03480-0","article-title":"A sedentary lifestyle changes the composition and predicted functions of the gut bacterial and fungal microbiota of subjects from the same company","volume":"80","author":"Xu","year":"2023","journal-title":"Curr Microbiol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00253-023-12912-7","article-title":"Phage cocktail alleviated type 2 diabetes by reshaping gut microbiota and decreasing proinflammatory cytokines","volume":"108","author":"Ye","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/jcm9051589","article-title":"Major lipids, apolipoproteins, and alterations of gut microbiota","volume":"9","author":"Yun","year":"2020","journal-title":"J. Clin. Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/nu15122728","article-title":"The impact of a very-low-calorie ketogenic diet in the gut microbiota composition in obesity","volume":"15","author":"Zambrano","year":"2023","journal-title":"Nutrients"},{"key":"B134","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12967-024-05175-x","article-title":"Impact of fundamental components of the Mediterranean diet on the microbiota composition in blood pressure regulation","volume":"22","author":"Zambrano","year":"","journal-title":"J. Transl. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1393182","DOI":"10.3389\/fnut.2024.1393182","article-title":"Microbiota dynamics preceding bariatric surgery as obesity treatment: a comprehensive review","volume":"11","author":"Zambrano","year":"","journal-title":"Front. Nutr."},{"key":"B136","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.3390\/ijms26146547","article-title":"The critical role of the bile acid receptor TGR5 in energy homeostasis: insights into physiology and therapeutic potential","volume":"26","author":"Zangerolamo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/ph18091372","article-title":"Drugs versus microbiota: how pharmacotherapy affects gut and probiotic bacteria","volume":"18","author":"Zawistowska-Rojek","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1333778","DOI":"10.3389\/fendo.2024.1333778","article-title":"Gut microbiota and therapy for obesity and type 2 diabetes","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Endocrinol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1535370217743765","article-title":"Featured article: structure moderation of gut microbiota in liraglutide-treated diabetic male rats","volume":"243","author":"Zhang","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imm.12896","article-title":"Adaptive immune education by gut microbiota antigens","volume":"154","author":"Zhao","year":"2018","journal-title":"Immunology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/metabo11080531","article-title":"The role of gut microbiota and its produced metabolites in obesity, dyslipidemia, adipocyte dysfunction, and its interventions","volume":"11","author":"Zwartjes","year":"2021","journal-title":"Metabolites"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1901528\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:25:40Z","timestamp":1783657540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1901528\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":141,"alternative-id":["10.3389\/fmicb.2026.1901528"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1901528","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"1901528"}}